Almazov Centre is among the top three recruiting countries for the number of patients with carotid artery atherosclerosis recruited in 2018.
For the second year running, the specialists from the Vascular Surgery Clinic supervised by Mikhail Chernyavsky, MD, DSc, have been taking part in the ongoing Asymptomatic Carotid Surgery Trial (ACST-2), an international randomised trial coordinated by the University of Oxford. The trial has been on track since 2008 and is recruiting patients from 101 hospitals in 33 countries worldwide. Currently, the trial includes 3,220 patients, the target being 3,600 patients.
The trial compares carotid endarterectomy (CEA) with carotid artery stenting (CAS) in the long-term prevention of stroke in patients with asymptomatic carotid stenosis. It should be noted that the top 10 recruiting countries include Italy, Spain, Great Britain, Austria, Poland and Hungary. Apart from Almazov Centre, there are other Russian hospitals taking part in the trial: Meshalkin National Medical Research Centre and Dzhanelidze Research Institute of Emergency Medicine.
The brilliant interim outcomes of surgeries performed by the specialists of the Vascular Surgery Clinic have shown the high professionalism of the surgical team of doctors and proven the safety and effectiveness of both methods for treating asymptomatic hemodynamically significant carotid stenosis. The team’s achievements were earlier noted at the joint symposium headed by the President of the European Society for Vascular Surgery that took place in Valencia (Spain).